HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Pipeline

Qiagen launches latest diagnostic for bloodstream infections

Qiagen has moved into syndromic testing for bloodstream infections with the launch of its newest offering.

By FierceBiotech · Apr 17, 2026 · via FierceBiotech
Qiagen launches latest diagnostic for bloodstream infections

Image: FierceBiotech

Tags
pipelineformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Pipeline
All Pipeline →
Small pools, big ideas: How the rare disease community is reimagining clinical trials
PipelineFierceBiotech ↗
Small pools, big ideas: How the rare disease community is reimagining clinical trials
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundre…
Apr 17, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window
PipelineFierceBiotech ↗
Labcorp launches rapid fentanyl test with 48-hour detection window
While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public healt…
Apr 17, 2026
Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
PipelineFierceBiotech ↗
Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
More than a year after licensing its PD-1xVEGF bispecific, Merck & Co. has finally unveiled the first clin…
Apr 17, 2026